Journal Article

DZNE-2022-00845

http://join2-wiki.gsi.de/foswiki/pub/Main/Artwork/join2_logo100x88.png Insomnia in neurological diseases.

Mayer, G. ; Happe, S. ; Evers, S. ; Hermann, W.DZNE* ; Jansen, S. ; Kallweit, U. ; Muntean, M.-L. ; Pöhlau, D. ; Riemann, D. ; Saletu, M. ; Schichl, M. ; Schmitt, W. J. ; Sixel-Döring, F. ; Young, P.

2021
BioMed Central [London]

This record in other databases:    

Please use a persistent id in citations: doi:10.1186/s42466-021-00106-3

Abstract: Insomnia is defined as difficulties of initiating and maintaining sleep, early awakening and poor subjective sleep quality despite adequate opportunity and circumstances for sleep with impairment of daytime performance. These components of insomnia - namely persistent sleep difficulties despite of adequate sleep opportunity resulting in daytime dysfunction - appear secondary or co-morbid to neurological diseases. Comorbid insomnia originates from neurodegenerative, inflammatory, traumatic or ischemic changes in sleep regulating brainstem and hypothalamic nuclei with consecutive changes of neurotransmitters. Symptoms of neurological disorders (i.e motor deficits), co-morbidities (i.e. pain, depression, anxiety) and some disease-specific pharmaceuticals may cause insomnia and/or other sleep problems.This guideline focuses on insomnias in headaches, neurodegenerative movement disorders, multiple sclerosis, traumatic brain injury, epilepsies, stroke, neuromuscular disease and dementia.The most important new recommendations are: Cognitive behavioral therapy (CBTi) is recommended to treat acute and chronic insomnia in headache patients. Insomnia is one of the most frequent sleep complaints in neurodegenerative movement disorders. Patients may benefit from CBTi, antidepressants (trazodone, doxepin), melatonin and gaba-agonists. Insomnia is a frequent precursor of MS symptoms by up to 10 years. CBTi is recommended in patients with MS, traumatic brain injury and. Melatonin may improve insomnia symptoms in children with epilepsies. Patients with insomnia after stroke can be treated with benzodiazepine receptor agonists and sedating antidepressants. For patients with dementia suffering from insomnia trazodone, light therapy and physical exercise are recommended.

Keyword(s): Classifications ; Cognitive behavioral therapy ; Comorbid diseases ; Diagnostic instruments ; Insomnia ; Neurological diseases ; Therapeutic recommendations

Note: (CC BY)

---

Contributing Institute(s):

1. Clinical Dementia Research Rostock /Greifswald (AG Teipel)

Research Program(s):

1. 353 - Clinical and Health Care Research (POF4-353) (POF4-353)

Appears in the scientific report 2021

---

Database coverage:
; ; ; ; DOAJ Seal

---